by christinehollinden | Feb 28, 2022 | News
Trudhesa: New Acute Migraine Treatment The Will Erwin Headache Research Foundation was founded with the mission to find a cure for cluster headaches and migraines as well as increase awareness about the different types of debilitating headaches and the lives of...
by christinehollinden | Jan 31, 2022 | News
New Preventative Migraine Medication QULIPTA Gets Approval From FDA Towards the end of 2021, a breakthrough has been made in the migraine research space as the U.S. FDA approved the use of a preventative treatment called QULIPTA. QULITPA In September 2021, the U.S....
by christinehollinden | Oct 12, 2021 | News
The Preventative Power of Nurtec and the Fight Against Migraines Migraines are more than just a “mild inconvenience” according to one recent study – they’ve become the third most prevalent illness in the world. The same source indicated that...
by christinehollinden | Sep 14, 2021 | News
As COVID-19 vaccines have become available — including Pfizer, Moderna, and Johnson & Johnson — many individuals who experience migraines and other headache disorders have wondered if those vaccines will impact their current, or potential, migraine treatments....
by christinehollinden | Aug 18, 2021 | News
Medication Overuse Headaches — Nurtec May Offer the Answer for Migraine Sufferers How does taking headache medicine too often result in a cycle of headaches? Many people reach for acute medicines for immediate relief when they have a headache. Unfortunately, if your...
by christinehollinden | Jul 14, 2021 | News
Hereditary Migraines Nearly 40 million people in the U.S. are affected by migraines. These headaches often affect one side of the head and have additional symptoms like light sensitivity, nausea, and vomiting. Sometimes migraine episodes accompanied or preceded by...
Recent Comments